nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—ADRA2A—epilepsy syndrome	0.403	1	CbGaD
Naphazoline—Antazoline—Phenytoin—epilepsy syndrome	0.305	1	CrCrCtD
Naphazoline—Terbinafine—CYP11A1—epilepsy syndrome	0.0011	0.265	CrCbGaD
Naphazoline—NISCH—telencephalon—epilepsy syndrome	0.00101	0.0749	CbGeAlD
Naphazoline—ADRA1A—hindbrain—epilepsy syndrome	0.000947	0.0706	CbGeAlD
Naphazoline—NISCH—medulla oblongata—epilepsy syndrome	0.00079	0.0589	CbGeAlD
Naphazoline—NISCH—midbrain—epilepsy syndrome	0.000722	0.0538	CbGeAlD
Naphazoline—Phentolamine—ADRA2A—epilepsy syndrome	0.00071	0.172	CrCbGaD
Naphazoline—NISCH—spinal cord—epilepsy syndrome	0.000704	0.0525	CbGeAlD
Naphazoline—Eye pain—Valproic Acid—epilepsy syndrome	0.000622	0.00408	CcSEcCtD
Naphazoline—Sweating—Felbamate—epilepsy syndrome	0.000604	0.00396	CcSEcCtD
Naphazoline—Hyperglycaemia—Phenytoin—epilepsy syndrome	0.000597	0.00391	CcSEcCtD
Naphazoline—Eye disorder—Midazolam—epilepsy syndrome	0.000597	0.00391	CcSEcCtD
Naphazoline—Discomfort—Lacosamide—epilepsy syndrome	0.000595	0.0039	CcSEcCtD
Naphazoline—Drowsiness—Clonazepam—epilepsy syndrome	0.000595	0.00389	CcSEcCtD
Naphazoline—Hyperglycaemia—Oxcarbazepine—epilepsy syndrome	0.000594	0.00389	CcSEcCtD
Naphazoline—Sweating—Zonisamide—epilepsy syndrome	0.000591	0.00387	CcSEcCtD
Naphazoline—Drowsiness—Phenytoin—epilepsy syndrome	0.000591	0.00387	CcSEcCtD
Naphazoline—Eye disorder—Levetiracetam—epilepsy syndrome	0.00059	0.00386	CcSEcCtD
Naphazoline—Lacrimation increased—Topiramate—epilepsy syndrome	0.000586	0.00384	CcSEcCtD
Naphazoline—Asthenia—Primidone—epilepsy syndrome	0.000577	0.00378	CcSEcCtD
Naphazoline—Hyperglycaemia—Carbamazepine—epilepsy syndrome	0.00057	0.00374	CcSEcCtD
Naphazoline—Erythema—Propofol—epilepsy syndrome	0.000569	0.00372	CcSEcCtD
Naphazoline—Sweating—Phenytoin—epilepsy syndrome	0.000566	0.00371	CcSEcCtD
Naphazoline—Drowsiness—Carbamazepine—epilepsy syndrome	0.000564	0.00369	CcSEcCtD
Naphazoline—Eye pain—Pregabalin—epilepsy syndrome	0.000563	0.00368	CcSEcCtD
Naphazoline—NISCH—cerebellum—epilepsy syndrome	0.000558	0.0416	CbGeAlD
Naphazoline—Hyperhidrosis—Lacosamide—epilepsy syndrome	0.000558	0.00366	CcSEcCtD
Naphazoline—Somnolence—Phenobarbital—epilepsy syndrome	0.000557	0.00365	CcSEcCtD
Naphazoline—Erythema—Midazolam—epilepsy syndrome	0.000556	0.00364	CcSEcCtD
Naphazoline—Eye disorder—Vigabatrin—epilepsy syndrome	0.000555	0.00363	CcSEcCtD
Naphazoline—Dizziness—Amobarbital—epilepsy syndrome	0.000552	0.00362	CcSEcCtD
Naphazoline—Hyperglycaemia—Lamotrigine—epilepsy syndrome	0.000551	0.00361	CcSEcCtD
Naphazoline—Somnolence—Rufinamide—epilepsy syndrome	0.000547	0.00358	CcSEcCtD
Naphazoline—Eye disorder—Diazepam—epilepsy syndrome	0.000546	0.00358	CcSEcCtD
Naphazoline—Tension—Midazolam—epilepsy syndrome	0.000546	0.00358	CcSEcCtD
Naphazoline—Drowsiness—Lamotrigine—epilepsy syndrome	0.000545	0.00357	CcSEcCtD
Naphazoline—ADRA1A—brainstem—epilepsy syndrome	0.000543	0.0405	CbGeAlD
Naphazoline—Hyperhidrosis—Clobazam—epilepsy syndrome	0.000542	0.00355	CcSEcCtD
Naphazoline—Nervousness—Midazolam—epilepsy syndrome	0.00054	0.00354	CcSEcCtD
Naphazoline—Tension—Levetiracetam—epilepsy syndrome	0.000539	0.00353	CcSEcCtD
Naphazoline—Nervousness—Levetiracetam—epilepsy syndrome	0.000534	0.0035	CcSEcCtD
Naphazoline—Dizziness—Primidone—epilepsy syndrome	0.000532	0.00348	CcSEcCtD
Naphazoline—Vision blurred—Midazolam—epilepsy syndrome	0.000524	0.00343	CcSEcCtD
Naphazoline—ADRA1A—forebrain—epilepsy syndrome	0.000524	0.0391	CbGeAlD
Naphazoline—Headache—Amobarbital—epilepsy syndrome	0.000523	0.00343	CcSEcCtD
Naphazoline—Sweating—Lamotrigine—epilepsy syndrome	0.000522	0.00342	CcSEcCtD
Naphazoline—Tension—Fosphenytoin—epilepsy syndrome	0.00052	0.00341	CcSEcCtD
Naphazoline—Vision blurred—Levetiracetam—epilepsy syndrome	0.000518	0.00339	CcSEcCtD
Naphazoline—Eye disorder—Zonisamide—epilepsy syndrome	0.000518	0.00339	CcSEcCtD
Naphazoline—Eye pain—Gabapentin—epilepsy syndrome	0.000516	0.00338	CcSEcCtD
Naphazoline—Nervousness—Fosphenytoin—epilepsy syndrome	0.000515	0.00337	CcSEcCtD
Naphazoline—Discomfort—Acetazolamide—epilepsy syndrome	0.000515	0.00337	CcSEcCtD
Naphazoline—Somnolence—Lacosamide—epilepsy syndrome	0.000513	0.00336	CcSEcCtD
Naphazoline—Erythema—Diazepam—epilepsy syndrome	0.000509	0.00333	CcSEcCtD
Naphazoline—Asthenia—Trimethadione—epilepsy syndrome	0.000508	0.00333	CcSEcCtD
Naphazoline—Tension—Vigabatrin—epilepsy syndrome	0.000507	0.00332	CcSEcCtD
Naphazoline—Headache—Primidone—epilepsy syndrome	0.000504	0.0033	CcSEcCtD
Naphazoline—Nervousness—Vigabatrin—epilepsy syndrome	0.000502	0.00329	CcSEcCtD
Naphazoline—Tension—Diazepam—epilepsy syndrome	0.000499	0.00327	CcSEcCtD
Naphazoline—Eye disorder—Clonazepam—epilepsy syndrome	0.000499	0.00327	CcSEcCtD
Naphazoline—Somnolence—Clobazam—epilepsy syndrome	0.000498	0.00326	CcSEcCtD
Naphazoline—Nausea—Amobarbital—epilepsy syndrome	0.000496	0.00325	CcSEcCtD
Naphazoline—Nervousness—Diazepam—epilepsy syndrome	0.000494	0.00324	CcSEcCtD
Naphazoline—Eye disorder—Oxcarbazepine—epilepsy syndrome	0.000493	0.00323	CcSEcCtD
Naphazoline—Hypertension—Propofol—epilepsy syndrome	0.000491	0.00322	CcSEcCtD
Naphazoline—Vision blurred—Vigabatrin—epilepsy syndrome	0.000487	0.00319	CcSEcCtD
Naphazoline—Tension—Felbamate—epilepsy syndrome	0.000483	0.00317	CcSEcCtD
Naphazoline—ADRA1A—telencephalon—epilepsy syndrome	0.000482	0.0359	CbGeAlD
Naphazoline—Vision blurred—Diazepam—epilepsy syndrome	0.00048	0.00314	CcSEcCtD
Naphazoline—Nervousness—Felbamate—epilepsy syndrome	0.000478	0.00313	CcSEcCtD
Naphazoline—Nausea—Primidone—epilepsy syndrome	0.000478	0.00313	CcSEcCtD
Naphazoline—Tension—Zonisamide—epilepsy syndrome	0.000473	0.0031	CcSEcCtD
Naphazoline—Eye disorder—Carbamazepine—epilepsy syndrome	0.000473	0.0031	CcSEcCtD
Naphazoline—Nervousness—Zonisamide—epilepsy syndrome	0.000468	0.00307	CcSEcCtD
Naphazoline—ADRA2C—telencephalon—epilepsy syndrome	0.000459	0.0342	CbGeAlD
Naphazoline—Hypertension—Fosphenytoin—epilepsy syndrome	0.000458	0.003	CcSEcCtD
Naphazoline—Eye disorder—Lamotrigine—epilepsy syndrome	0.000457	0.00299	CcSEcCtD
Naphazoline—Tension—Clonazepam—epilepsy syndrome	0.000456	0.00299	CcSEcCtD
Naphazoline—NISCH—brain—epilepsy syndrome	0.000454	0.0338	CbGeAlD
Naphazoline—Tension—Phenytoin—epilepsy syndrome	0.000453	0.00297	CcSEcCtD
Naphazoline—Nervousness—Clonazepam—epilepsy syndrome	0.000451	0.00296	CcSEcCtD
Naphazoline—Tension—Oxcarbazepine—epilepsy syndrome	0.00045	0.00295	CcSEcCtD
Naphazoline—Hyperhidrosis—Propofol—epilepsy syndrome	0.000449	0.00294	CcSEcCtD
Naphazoline—Nervousness—Phenytoin—epilepsy syndrome	0.000448	0.00294	CcSEcCtD
Naphazoline—Discomfort—Fosphenytoin—epilepsy syndrome	0.000446	0.00292	CcSEcCtD
Naphazoline—Nervousness—Oxcarbazepine—epilepsy syndrome	0.000446	0.00292	CcSEcCtD
Naphazoline—Somnolence—Acetazolamide—epilepsy syndrome	0.000444	0.00291	CcSEcCtD
Naphazoline—Headache—Trimethadione—epilepsy syndrome	0.000443	0.0029	CcSEcCtD
Naphazoline—Asthenia—Rufinamide—epilepsy syndrome	0.000441	0.00289	CcSEcCtD
Naphazoline—Erythema—Carbamazepine—epilepsy syndrome	0.000441	0.00289	CcSEcCtD
Naphazoline—Vision blurred—Clonazepam—epilepsy syndrome	0.000438	0.00287	CcSEcCtD
Naphazoline—Discomfort—Vigabatrin—epilepsy syndrome	0.000435	0.00285	CcSEcCtD
Naphazoline—Eye pain—Topiramate—epilepsy syndrome	0.000434	0.00284	CcSEcCtD
Naphazoline—Drowsiness—Valproic Acid—epilepsy syndrome	0.000433	0.00284	CcSEcCtD
Naphazoline—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000433	0.00283	CcSEcCtD
Naphazoline—Tension—Carbamazepine—epilepsy syndrome	0.000432	0.00283	CcSEcCtD
Naphazoline—Discomfort—Diazepam—epilepsy syndrome	0.000428	0.0028	CcSEcCtD
Naphazoline—Nervousness—Carbamazepine—epilepsy syndrome	0.000428	0.0028	CcSEcCtD
Naphazoline—Erythema—Lamotrigine—epilepsy syndrome	0.000426	0.00279	CcSEcCtD
Naphazoline—Hypertension—Felbamate—epilepsy syndrome	0.000425	0.00278	CcSEcCtD
Naphazoline—Nausea—Trimethadione—epilepsy syndrome	0.00042	0.00275	CcSEcCtD
Naphazoline—Terbinafine—CYP2C19—epilepsy syndrome	0.000419	0.101	CrCbGaD
Naphazoline—Tolazoline—ADRA2A—epilepsy syndrome	0.000418	0.101	CrCbGaD
Naphazoline—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000418	0.00274	CcSEcCtD
Naphazoline—Tension—Lamotrigine—epilepsy syndrome	0.000418	0.00274	CcSEcCtD
Naphazoline—Hypertension—Zonisamide—epilepsy syndrome	0.000416	0.00273	CcSEcCtD
Naphazoline—Vision blurred—Carbamazepine—epilepsy syndrome	0.000415	0.00272	CcSEcCtD
Naphazoline—Sweating—Valproic Acid—epilepsy syndrome	0.000415	0.00272	CcSEcCtD
Naphazoline—Asthenia—Lacosamide—epilepsy syndrome	0.000414	0.00271	CcSEcCtD
Naphazoline—Dizziness—Phenobarbital—epilepsy syndrome	0.000414	0.00271	CcSEcCtD
Naphazoline—Discomfort—Felbamate—epilepsy syndrome	0.000414	0.00271	CcSEcCtD
Naphazoline—Nervousness—Lamotrigine—epilepsy syndrome	0.000413	0.00271	CcSEcCtD
Naphazoline—Somnolence—Propofol—epilepsy syndrome	0.000413	0.0027	CcSEcCtD
Naphazoline—Dizziness—Rufinamide—epilepsy syndrome	0.000407	0.00266	CcSEcCtD
Naphazoline—Discomfort—Zonisamide—epilepsy syndrome	0.000405	0.00266	CcSEcCtD
Naphazoline—Somnolence—Midazolam—epilepsy syndrome	0.000404	0.00264	CcSEcCtD
Naphazoline—Asthenia—Clobazam—epilepsy syndrome	0.000402	0.00263	CcSEcCtD
Naphazoline—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000401	0.00263	CcSEcCtD
Naphazoline—Vision blurred—Lamotrigine—epilepsy syndrome	0.000401	0.00263	CcSEcCtD
Naphazoline—Somnolence—Levetiracetam—epilepsy syndrome	0.000399	0.00261	CcSEcCtD
Naphazoline—ADRA2A—forebrain—epilepsy syndrome	0.000398	0.0297	CbGeAlD
Naphazoline—Hypertension—Phenytoin—epilepsy syndrome	0.000398	0.00261	CcSEcCtD
Naphazoline—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000396	0.0026	CcSEcCtD
Naphazoline—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.000396	0.00259	CcSEcCtD
Naphazoline—Headache—Phenobarbital—epilepsy syndrome	0.000393	0.00257	CcSEcCtD
Naphazoline—Discomfort—Clonazepam—epilepsy syndrome	0.000391	0.00256	CcSEcCtD
Naphazoline—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000389	0.00255	CcSEcCtD
Naphazoline—Discomfort—Phenytoin—epilepsy syndrome	0.000388	0.00254	CcSEcCtD
Naphazoline—Discomfort—Oxcarbazepine—epilepsy syndrome	0.000386	0.00253	CcSEcCtD
Naphazoline—Headache—Rufinamide—epilepsy syndrome	0.000385	0.00252	CcSEcCtD
Naphazoline—Somnolence—Fosphenytoin—epilepsy syndrome	0.000385	0.00252	CcSEcCtD
Naphazoline—Dizziness—Lacosamide—epilepsy syndrome	0.000382	0.0025	CcSEcCtD
Naphazoline—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.00038	0.00249	CcSEcCtD
Naphazoline—Hypertension—Carbamazepine—epilepsy syndrome	0.00038	0.00249	CcSEcCtD
Naphazoline—Sweating—Pregabalin—epilepsy syndrome	0.000375	0.00246	CcSEcCtD
Naphazoline—Somnolence—Vigabatrin—epilepsy syndrome	0.000375	0.00246	CcSEcCtD
Naphazoline—Nausea—Phenobarbital—epilepsy syndrome	0.000372	0.00244	CcSEcCtD
Naphazoline—Dizziness—Clobazam—epilepsy syndrome	0.000371	0.00243	CcSEcCtD
Naphazoline—Somnolence—Diazepam—epilepsy syndrome	0.000369	0.00242	CcSEcCtD
Naphazoline—Hypertension—Lamotrigine—epilepsy syndrome	0.000368	0.00241	CcSEcCtD
Naphazoline—ADRA2A—telencephalon—epilepsy syndrome	0.000366	0.0273	CbGeAlD
Naphazoline—Nausea—Rufinamide—epilepsy syndrome	0.000365	0.00239	CcSEcCtD
Naphazoline—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000364	0.00238	CcSEcCtD
Naphazoline—Eye disorder—Valproic Acid—epilepsy syndrome	0.000363	0.00238	CcSEcCtD
Naphazoline—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.000363	0.00238	CcSEcCtD
Naphazoline—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000362	0.00237	CcSEcCtD
Naphazoline—Headache—Lacosamide—epilepsy syndrome	0.000362	0.00237	CcSEcCtD
Naphazoline—ADRA2C—medulla oblongata—epilepsy syndrome	0.000361	0.0269	CbGeAlD
Naphazoline—Drowsiness—Gabapentin—epilepsy syndrome	0.000359	0.00235	CcSEcCtD
Naphazoline—Asthenia—Acetazolamide—epilepsy syndrome	0.000358	0.00235	CcSEcCtD
Naphazoline—Discomfort—Lamotrigine—epilepsy syndrome	0.000358	0.00235	CcSEcCtD
Naphazoline—Somnolence—Felbamate—epilepsy syndrome	0.000357	0.00234	CcSEcCtD
Naphazoline—Headache—Clobazam—epilepsy syndrome	0.000351	0.0023	CcSEcCtD
Naphazoline—Somnolence—Zonisamide—epilepsy syndrome	0.00035	0.00229	CcSEcCtD
Naphazoline—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000348	0.00228	CcSEcCtD
Naphazoline—Sweating—Gabapentin—epilepsy syndrome	0.000344	0.00225	CcSEcCtD
Naphazoline—Nausea—Lacosamide—epilepsy syndrome	0.000343	0.00225	CcSEcCtD
Naphazoline—Somnolence—Clonazepam—epilepsy syndrome	0.000337	0.00221	CcSEcCtD
Naphazoline—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000336	0.0022	CcSEcCtD
Naphazoline—Somnolence—Phenytoin—epilepsy syndrome	0.000335	0.00219	CcSEcCtD
Naphazoline—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000333	0.00218	CcSEcCtD
Naphazoline—Nausea—Clobazam—epilepsy syndrome	0.000333	0.00218	CcSEcCtD
Naphazoline—Asthenia—Propofol—epilepsy syndrome	0.000333	0.00218	CcSEcCtD
Naphazoline—Duloxetine—SLC6A4—epilepsy syndrome	0.000333	0.0806	CrCbGaD
Naphazoline—Tension—Valproic Acid—epilepsy syndrome	0.000332	0.00217	CcSEcCtD
Naphazoline—Dizziness—Acetazolamide—epilepsy syndrome	0.00033	0.00216	CcSEcCtD
Naphazoline—ADRA2C—midbrain—epilepsy syndrome	0.00033	0.0246	CbGeAlD
Naphazoline—Nervousness—Valproic Acid—epilepsy syndrome	0.000329	0.00215	CcSEcCtD
Naphazoline—Eye disorder—Pregabalin—epilepsy syndrome	0.000328	0.00215	CcSEcCtD
Naphazoline—Asthenia—Midazolam—epilepsy syndrome	0.000326	0.00213	CcSEcCtD
Naphazoline—Asthenia—Levetiracetam—epilepsy syndrome	0.000322	0.00211	CcSEcCtD
Naphazoline—ADRA2C—spinal cord—epilepsy syndrome	0.000322	0.024	CbGeAlD
Naphazoline—Somnolence—Carbamazepine—epilepsy syndrome	0.00032	0.00209	CcSEcCtD
Naphazoline—Vision blurred—Valproic Acid—epilepsy syndrome	0.000319	0.00209	CcSEcCtD
Naphazoline—Headache—Acetazolamide—epilepsy syndrome	0.000313	0.00205	CcSEcCtD
Naphazoline—Asthenia—Fosphenytoin—epilepsy syndrome	0.00031	0.00203	CcSEcCtD
Naphazoline—Terbinafine—CYP2D6—epilepsy syndrome	0.00031	0.0751	CrCbGaD
Naphazoline—Somnolence—Lamotrigine—epilepsy syndrome	0.000309	0.00202	CcSEcCtD
Naphazoline—Dizziness—Propofol—epilepsy syndrome	0.000307	0.00201	CcSEcCtD
Naphazoline—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000305	0.002	CcSEcCtD
Naphazoline—Asthenia—Vigabatrin—epilepsy syndrome	0.000303	0.00198	CcSEcCtD
Naphazoline—Eye disorder—Gabapentin—epilepsy syndrome	0.000301	0.00197	CcSEcCtD
Naphazoline—Dizziness—Midazolam—epilepsy syndrome	0.0003	0.00197	CcSEcCtD
Naphazoline—Tension—Pregabalin—epilepsy syndrome	0.0003	0.00197	CcSEcCtD
Naphazoline—ADRA1A—head—epilepsy syndrome	0.0003	0.0224	CbGeAlD
Naphazoline—Asthenia—Diazepam—epilepsy syndrome	0.000298	0.00195	CcSEcCtD
Naphazoline—Nervousness—Pregabalin—epilepsy syndrome	0.000297	0.00195	CcSEcCtD
Naphazoline—Nausea—Acetazolamide—epilepsy syndrome	0.000297	0.00194	CcSEcCtD
Naphazoline—Dizziness—Levetiracetam—epilepsy syndrome	0.000297	0.00194	CcSEcCtD
Naphazoline—Hypertension—Valproic Acid—epilepsy syndrome	0.000292	0.00191	CcSEcCtD
Naphazoline—Headache—Propofol—epilepsy syndrome	0.000291	0.0019	CcSEcCtD
Naphazoline—Asthenia—Felbamate—epilepsy syndrome	0.000288	0.00189	CcSEcCtD
Naphazoline—Vision blurred—Pregabalin—epilepsy syndrome	0.000288	0.00189	CcSEcCtD
Naphazoline—ADRA2A—medulla oblongata—epilepsy syndrome	0.000288	0.0215	CbGeAlD
Naphazoline—Dizziness—Fosphenytoin—epilepsy syndrome	0.000286	0.00187	CcSEcCtD
Naphazoline—ADRA2C—head—epilepsy syndrome	0.000286	0.0213	CbGeAlD
Naphazoline—Discomfort—Valproic Acid—epilepsy syndrome	0.000285	0.00186	CcSEcCtD
Naphazoline—ADRA1A—nervous system—epilepsy syndrome	0.000284	0.0212	CbGeAlD
Naphazoline—Headache—Midazolam—epilepsy syndrome	0.000284	0.00186	CcSEcCtD
Naphazoline—Asthenia—Zonisamide—epilepsy syndrome	0.000282	0.00185	CcSEcCtD
Naphazoline—Headache—Levetiracetam—epilepsy syndrome	0.000281	0.00184	CcSEcCtD
Naphazoline—Erythema—Gabapentin—epilepsy syndrome	0.00028	0.00184	CcSEcCtD
Naphazoline—Dizziness—Vigabatrin—epilepsy syndrome	0.000279	0.00183	CcSEcCtD
Naphazoline—Nausea—Propofol—epilepsy syndrome	0.000276	0.00181	CcSEcCtD
Naphazoline—Tension—Gabapentin—epilepsy syndrome	0.000275	0.0018	CcSEcCtD
Naphazoline—Dizziness—Diazepam—epilepsy syndrome	0.000275	0.0018	CcSEcCtD
Naphazoline—ADRA1A—central nervous system—epilepsy syndrome	0.000274	0.0204	CbGeAlD
Naphazoline—Nervousness—Gabapentin—epilepsy syndrome	0.000272	0.00178	CcSEcCtD
Naphazoline—Asthenia—Clonazepam—epilepsy syndrome	0.000272	0.00178	CcSEcCtD
Naphazoline—Headache—Fosphenytoin—epilepsy syndrome	0.000271	0.00178	CcSEcCtD
Naphazoline—ADRA2C—nervous system—epilepsy syndrome	0.000271	0.0202	CbGeAlD
Naphazoline—Asthenia—Phenytoin—epilepsy syndrome	0.00027	0.00177	CcSEcCtD
Naphazoline—Nausea—Midazolam—epilepsy syndrome	0.00027	0.00177	CcSEcCtD
Naphazoline—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000269	0.00176	CcSEcCtD
Naphazoline—ADRA1A—cerebellum—epilepsy syndrome	0.000268	0.02	CbGeAlD
Naphazoline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000267	0.00175	CcSEcCtD
Naphazoline—Nausea—Levetiracetam—epilepsy syndrome	0.000266	0.00174	CcSEcCtD
Naphazoline—Dizziness—Felbamate—epilepsy syndrome	0.000266	0.00174	CcSEcCtD
Naphazoline—Vision blurred—Gabapentin—epilepsy syndrome	0.000264	0.00173	CcSEcCtD
Naphazoline—Headache—Vigabatrin—epilepsy syndrome	0.000264	0.00173	CcSEcCtD
Naphazoline—Hypertension—Pregabalin—epilepsy syndrome	0.000264	0.00173	CcSEcCtD
Naphazoline—ADRA2A—midbrain—epilepsy syndrome	0.000263	0.0196	CbGeAlD
Naphazoline—ADRA2C—central nervous system—epilepsy syndrome	0.000261	0.0195	CbGeAlD
Naphazoline—Dizziness—Zonisamide—epilepsy syndrome	0.00026	0.0017	CcSEcCtD
Naphazoline—Headache—Diazepam—epilepsy syndrome	0.00026	0.0017	CcSEcCtD
Naphazoline—Asthenia—Carbamazepine—epilepsy syndrome	0.000258	0.00169	CcSEcCtD
Naphazoline—Discomfort—Pregabalin—epilepsy syndrome	0.000257	0.00169	CcSEcCtD
Naphazoline—Nausea—Fosphenytoin—epilepsy syndrome	0.000257	0.00168	CcSEcCtD
Naphazoline—ADRA2A—spinal cord—epilepsy syndrome	0.000257	0.0191	CbGeAlD
Naphazoline—Duloxetine—HTR2A—epilepsy syndrome	0.000256	0.0619	CrCbGaD
Naphazoline—ADRA2C—cerebellum—epilepsy syndrome	0.000255	0.019	CbGeAlD
Naphazoline—Eye disorder—Topiramate—epilepsy syndrome	0.000253	0.00166	CcSEcCtD
Naphazoline—Headache—Felbamate—epilepsy syndrome	0.000252	0.00165	CcSEcCtD
Naphazoline—Dizziness—Clonazepam—epilepsy syndrome	0.000251	0.00164	CcSEcCtD
Naphazoline—Nausea—Vigabatrin—epilepsy syndrome	0.000251	0.00164	CcSEcCtD
Naphazoline—Asthenia—Lamotrigine—epilepsy syndrome	0.000249	0.00163	CcSEcCtD
Naphazoline—Dizziness—Phenytoin—epilepsy syndrome	0.000249	0.00163	CcSEcCtD
Naphazoline—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000248	0.00162	CcSEcCtD
Naphazoline—Nausea—Diazepam—epilepsy syndrome	0.000247	0.00162	CcSEcCtD
Naphazoline—Headache—Zonisamide—epilepsy syndrome	0.000246	0.00161	CcSEcCtD
Naphazoline—Somnolence—Valproic Acid—epilepsy syndrome	0.000245	0.00161	CcSEcCtD
Naphazoline—Hypertension—Gabapentin—epilepsy syndrome	0.000242	0.00159	CcSEcCtD
Naphazoline—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000241	0.00158	CcSEcCtD
Naphazoline—Nausea—Felbamate—epilepsy syndrome	0.000239	0.00156	CcSEcCtD
Naphazoline—Dizziness—Carbamazepine—epilepsy syndrome	0.000238	0.00156	CcSEcCtD
Naphazoline—Headache—Clonazepam—epilepsy syndrome	0.000238	0.00156	CcSEcCtD
Naphazoline—Headache—Phenytoin—epilepsy syndrome	0.000236	0.00155	CcSEcCtD
Naphazoline—Erythema—Topiramate—epilepsy syndrome	0.000236	0.00155	CcSEcCtD
Naphazoline—Discomfort—Gabapentin—epilepsy syndrome	0.000236	0.00155	CcSEcCtD
Naphazoline—Headache—Oxcarbazepine—epilepsy syndrome	0.000235	0.00154	CcSEcCtD
Naphazoline—Duloxetine—CYP2D6—epilepsy syndrome	0.000234	0.0566	CrCbGaD
Naphazoline—Nausea—Zonisamide—epilepsy syndrome	0.000234	0.00153	CcSEcCtD
Naphazoline—Tension—Topiramate—epilepsy syndrome	0.000232	0.00152	CcSEcCtD
Naphazoline—Dizziness—Lamotrigine—epilepsy syndrome	0.00023	0.0015	CcSEcCtD
Naphazoline—Nervousness—Topiramate—epilepsy syndrome	0.000229	0.0015	CcSEcCtD
Naphazoline—ADRA2A—head—epilepsy syndrome	0.000228	0.017	CbGeAlD
Naphazoline—Nausea—Clonazepam—epilepsy syndrome	0.000225	0.00148	CcSEcCtD
Naphazoline—Headache—Carbamazepine—epilepsy syndrome	0.000225	0.00148	CcSEcCtD
Naphazoline—Nausea—Phenytoin—epilepsy syndrome	0.000224	0.00147	CcSEcCtD
Naphazoline—Nausea—Oxcarbazepine—epilepsy syndrome	0.000223	0.00146	CcSEcCtD
Naphazoline—Vision blurred—Topiramate—epilepsy syndrome	0.000222	0.00146	CcSEcCtD
Naphazoline—Somnolence—Pregabalin—epilepsy syndrome	0.000222	0.00145	CcSEcCtD
Naphazoline—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000221	0.00145	CcSEcCtD
Naphazoline—Headache—Lamotrigine—epilepsy syndrome	0.000218	0.00143	CcSEcCtD
Naphazoline—ADRA1A—brain—epilepsy syndrome	0.000217	0.0162	CbGeAlD
Naphazoline—ADRA2A—nervous system—epilepsy syndrome	0.000216	0.0161	CbGeAlD
Naphazoline—Nausea—Carbamazepine—epilepsy syndrome	0.000214	0.0014	CcSEcCtD
Naphazoline—ADRA2A—central nervous system—epilepsy syndrome	0.000208	0.0155	CbGeAlD
Naphazoline—ADRA2C—brain—epilepsy syndrome	0.000207	0.0154	CbGeAlD
Naphazoline—Nausea—Lamotrigine—epilepsy syndrome	0.000206	0.00135	CcSEcCtD
Naphazoline—Hypertension—Topiramate—epilepsy syndrome	0.000204	0.00133	CcSEcCtD
Naphazoline—ADRA2A—cerebellum—epilepsy syndrome	0.000204	0.0152	CbGeAlD
Naphazoline—Somnolence—Gabapentin—epilepsy syndrome	0.000203	0.00133	CcSEcCtD
Naphazoline—Discomfort—Topiramate—epilepsy syndrome	0.000198	0.0013	CcSEcCtD
Naphazoline—Asthenia—Valproic Acid—epilepsy syndrome	0.000198	0.0013	CcSEcCtD
Naphazoline—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000186	0.00122	CcSEcCtD
Naphazoline—Dizziness—Valproic Acid—epilepsy syndrome	0.000183	0.0012	CcSEcCtD
Naphazoline—Asthenia—Pregabalin—epilepsy syndrome	0.000179	0.00117	CcSEcCtD
Naphazoline—Headache—Valproic Acid—epilepsy syndrome	0.000173	0.00113	CcSEcCtD
Naphazoline—Somnolence—Topiramate—epilepsy syndrome	0.000171	0.00112	CcSEcCtD
Naphazoline—ADRA2A—brain—epilepsy syndrome	0.000165	0.0123	CbGeAlD
Naphazoline—Dizziness—Pregabalin—epilepsy syndrome	0.000165	0.00108	CcSEcCtD
Naphazoline—Asthenia—Gabapentin—epilepsy syndrome	0.000164	0.00108	CcSEcCtD
Naphazoline—Nausea—Valproic Acid—epilepsy syndrome	0.000164	0.00107	CcSEcCtD
Naphazoline—Propranolol—CYP2C19—epilepsy syndrome	0.000157	0.038	CrCbGaD
Naphazoline—Headache—Pregabalin—epilepsy syndrome	0.000156	0.00102	CcSEcCtD
Naphazoline—Dizziness—Gabapentin—epilepsy syndrome	0.000151	0.000991	CcSEcCtD
Naphazoline—Nausea—Pregabalin—epilepsy syndrome	0.000148	0.000971	CcSEcCtD
Naphazoline—Headache—Gabapentin—epilepsy syndrome	0.000143	0.000939	CcSEcCtD
Naphazoline—Asthenia—Topiramate—epilepsy syndrome	0.000138	0.000905	CcSEcCtD
Naphazoline—Nausea—Gabapentin—epilepsy syndrome	0.000136	0.00089	CcSEcCtD
Naphazoline—Dizziness—Topiramate—epilepsy syndrome	0.000127	0.000834	CcSEcCtD
Naphazoline—Headache—Topiramate—epilepsy syndrome	0.000121	0.00079	CcSEcCtD
Naphazoline—Propranolol—CYP2D6—epilepsy syndrome	0.000116	0.0282	CrCbGaD
Naphazoline—Nausea—Topiramate—epilepsy syndrome	0.000114	0.000749	CcSEcCtD
Naphazoline—Propranolol—ABCB1—epilepsy syndrome	8.31e-05	0.0201	CrCbGaD
Naphazoline—ADRA2C—Signaling Pathways—DUSP6—epilepsy syndrome	1.14e-05	9.36e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CNR1—epilepsy syndrome	1.13e-05	9.33e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—JUNB—epilepsy syndrome	1.13e-05	9.33e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.13e-05	9.3e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRA2A—epilepsy syndrome	1.12e-05	9.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.12e-05	9.21e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.12e-05	9.21e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLAT—epilepsy syndrome	1.12e-05	9.2e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.11e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR7—epilepsy syndrome	1.11e-05	9.1e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—SRC—epilepsy syndrome	1.1e-05	9.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	1.1e-05	9.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.1e-05	9.02e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.09e-05	9.01e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—BCHE—epilepsy syndrome	1.09e-05	8.94e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL12—epilepsy syndrome	1.08e-05	8.88e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BDKRB2—epilepsy syndrome	1.08e-05	8.88e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—epilepsy syndrome	1.08e-05	8.87e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.08e-05	8.86e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PRKCB—epilepsy syndrome	1.07e-05	8.84e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.07e-05	8.84e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VEGFA—epilepsy syndrome	1.07e-05	8.81e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.07e-05	8.81e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6ST—epilepsy syndrome	1.07e-05	8.8e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	1.07e-05	8.79e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—JUNB—epilepsy syndrome	1.06e-05	8.71e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CNR1—epilepsy syndrome	1.06e-05	8.71e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLCB1—epilepsy syndrome	1.06e-05	8.68e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT3—epilepsy syndrome	1.05e-05	8.67e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—HMOX1—epilepsy syndrome	1.05e-05	8.64e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—epilepsy syndrome	1.05e-05	8.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	1.04e-05	8.56e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	1.04e-05	8.53e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAT—epilepsy syndrome	1.04e-05	8.52e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.03e-05	8.51e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR7—epilepsy syndrome	1.03e-05	8.5e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	1.03e-05	8.49e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.03e-05	8.49e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.03e-05	8.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	1.03e-05	8.43e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.03e-05	8.43e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TH—epilepsy syndrome	1.02e-05	8.4e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.02e-05	8.37e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	1.02e-05	8.36e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ABCB1—epilepsy syndrome	1.01e-05	8.29e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	1e-05	8.26e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	1e-05	8.26e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	1e-05	8.26e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	1e-05	8.25e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.96e-06	8.19e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	9.95e-06	8.18e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	9.85e-06	8.1e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	9.82e-06	8.08e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	9.79e-06	8.05e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	9.78e-06	8.04e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	9.74e-06	8.01e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	9.65e-06	7.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	9.62e-06	7.91e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	9.62e-06	7.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.61e-06	7.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	9.59e-06	7.88e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	9.59e-06	7.88e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	9.58e-06	7.88e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	9.45e-06	7.77e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	9.44e-06	7.76e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	9.44e-06	7.76e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	9.42e-06	7.75e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	9.39e-06	7.73e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GPX1—epilepsy syndrome	9.37e-06	7.71e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	9.36e-06	7.69e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	9.33e-06	7.67e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	9.33e-06	7.67e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	9.33e-06	7.67e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	9.32e-06	7.66e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	9.26e-06	7.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	9.26e-06	7.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	9.24e-06	7.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	9.23e-06	7.59e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	9.1e-06	7.48e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	9.09e-06	7.47e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	9.04e-06	7.43e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	9.01e-06	7.41e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	8.99e-06	7.39e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SRC—epilepsy syndrome	8.94e-06	7.35e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	8.81e-06	7.24e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	8.77e-06	7.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	8.77e-06	7.21e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	8.77e-06	7.21e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	8.76e-06	7.2e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	8.73e-06	7.18e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	8.7e-06	7.16e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	8.7e-06	7.16e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	8.69e-06	7.15e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	8.61e-06	7.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	8.61e-06	7.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	8.61e-06	7.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	8.58e-06	7.05e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	8.57e-06	7.04e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	8.56e-06	7.04e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	8.54e-06	7.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	8.53e-06	7.01e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	8.52e-06	7.01e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAT—epilepsy syndrome	8.42e-06	6.92e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	8.41e-06	6.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	8.4e-06	6.91e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	8.37e-06	6.89e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	8.23e-06	6.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	8.23e-06	6.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AGT—epilepsy syndrome	8.22e-06	6.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	8.19e-06	6.73e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	8.15e-06	6.7e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	8.14e-06	6.7e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOE—epilepsy syndrome	8.05e-06	6.62e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	8e-06	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	8e-06	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	7.97e-06	6.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	7.96e-06	6.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	7.95e-06	6.54e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	7.95e-06	6.54e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	7.92e-06	6.51e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	7.88e-06	6.48e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	7.86e-06	6.46e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	7.82e-06	6.43e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	7.78e-06	6.4e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	7.75e-06	6.38e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	7.69e-06	6.33e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GPX1—epilepsy syndrome	7.61e-06	6.26e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	7.61e-06	6.26e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	7.61e-06	6.26e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	7.4e-06	6.09e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	7.39e-06	6.08e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	7.36e-06	6.06e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	7.35e-06	6.05e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	7.32e-06	6.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	7.32e-06	6.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	7.3e-06	6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	7.24e-06	5.95e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	7.21e-06	5.93e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	7.19e-06	5.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	7.07e-06	5.81e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	7.06e-06	5.81e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	6.99e-06	5.75e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	6.97e-06	5.73e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	6.96e-06	5.72e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—epilepsy syndrome	6.92e-06	5.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	6.88e-06	5.66e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	6.87e-06	5.65e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	6.84e-06	5.62e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	6.8e-06	5.59e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	6.77e-06	5.57e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	6.73e-06	5.54e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.72e-06	5.53e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	6.68e-06	5.5e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AGT—epilepsy syndrome	6.67e-06	5.49e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	6.65e-06	5.47e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	6.59e-06	5.42e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—epilepsy syndrome	6.54e-06	5.38e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	6.5e-06	5.35e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	6.48e-06	5.33e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	6.47e-06	5.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	6.46e-06	5.32e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	6.35e-06	5.22e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	6.33e-06	5.21e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.32e-06	5.2e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—epilepsy syndrome	6.3e-06	5.19e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.25e-06	5.14e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	6.19e-06	5.09e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	6.18e-06	5.08e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	6.06e-06	4.98e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	6.01e-06	4.95e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	6.01e-06	4.94e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	6.01e-06	4.94e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	5.88e-06	4.84e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.88e-06	4.84e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	5.78e-06	4.76e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	5.76e-06	4.74e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	5.66e-06	4.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.62e-06	4.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.59e-06	4.59e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.58e-06	4.59e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	5.55e-06	4.57e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	5.55e-06	4.56e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	5.53e-06	4.55e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	5.52e-06	4.54e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.47e-06	4.5e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	5.47e-06	4.5e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	5.36e-06	4.41e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	5.16e-06	4.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	5.14e-06	4.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—epilepsy syndrome	5.12e-06	4.21e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	5.11e-06	4.21e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	5.08e-06	4.18e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	5.06e-06	4.16e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.98e-06	4.1e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	4.95e-06	4.07e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	4.75e-06	3.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.7e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	4.65e-06	3.83e-05	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.63e-06	3.8e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.6e-06	3.78e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.58e-06	3.77e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.48e-06	3.68e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	4.47e-06	3.68e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	4.45e-06	3.66e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.33e-06	3.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.32e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	4.28e-06	3.52e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.2e-06	3.46e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	4.16e-06	3.42e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	4.15e-06	3.42e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	4.15e-06	3.41e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	4.07e-06	3.35e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	4.05e-06	3.33e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.99e-06	3.28e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.92e-06	3.23e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.89e-06	3.2e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.86e-06	3.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.78e-06	3.11e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.78e-06	3.11e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.74e-06	3.08e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.73e-06	3.07e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	3.64e-06	2.99e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.63e-06	2.99e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	3.54e-06	2.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.51e-06	2.89e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.48e-06	2.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.43e-06	2.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.38e-06	2.78e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.29e-06	2.7e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	3.26e-06	2.68e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.19e-06	2.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.03e-06	2.49e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.95e-06	2.43e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.77e-06	2.28e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.48e-06	2.04e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.32e-06	1.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.25e-06	1.85e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.03e-06	1.67e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.88e-06	1.55e-05	CbGpPWpGaD
